Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30080068HIVENSG00000134259.6protein_codingNGFNoNo4803P01138
TVIS20066036HPVENSG00000134259.6protein_codingNGFNoNo4803P01138
TVIS44024356HTLV-1ENSG00000134259.6protein_codingNGFNoNo4803P01138
TCGA Plot Options
Drug Information
GeneNGF
DrugBank IDDB01407
Drug NameClenbuterol
Target IDBE0001094
UniProt IDP01138
Regulation Typestimulator
PubMed IDs10403429; 10525174; 10637819; 11146120; 11221812
CitationsCulmsee C, Semkova I, Krieglstein J: NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense study. Neurochem Int. 1999 Jul;35(1):47-57.@@Semkova I, Krieglstein J: Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res Brain Res Rev. 1999 Aug;30(2):176-88.@@Puls I, Beck M, Giess R, Magnus T, Ochs G, Toyka KV: [Clenbuterol in amyotrophic lateral sclerosis. No indication for a positive effect]. Nervenarzt. 1999 Dec;70(12):1112-5.@@Samina Riaz S, Tomlinson DR: Pharmacological modulation of nerve growth factor synthesis: a mechanistic comparison of vitamin D receptor and beta(2)-adrenoceptor agonists. Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):179-88.@@Riaz SS, Tomlinson DR: Clenbuterol stimulates neurotrophic support in streptozotocin-diabetic rats. Diabetes Obes Metab. 1999 Jan;1(1):43-51.
GroupsApproved; Investigational; Vet_approved
Direct ClassificationDichlorobenzenes
SMILESCC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1
Pathways
PharmGKBPA164745640
ChEMBLCHEMBL49080